United States · Platforms & data · MarketBeat

Pfizer (NYSE:PFE) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Published by MarketBeat · United States 1 h ago

Royal Bank Of Canada raised their price objective on Pfizer from $25.00 to $28.00 and gave the stock a "sector perform" rating in a report on Wednesday.

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

Seeking Alpha

10-year Treasury yield slides as traders mull over Democrats' midterm victories, oil prices drop

TheStreet

Pfizer (NYSE:PFE) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Share

Also worth reading

Ralliant Corporation Non-GAAP EPS of $0.93, revenue of $620M

Novo Nordisk (NVO) Q3 2026 Earnings Call Transcript

These 12 stocks are good bets to beat the 10-year Treasury over the next decade

Eversource Energy earnings on deck after Q2 miss, estimate cuts

10-year Treasury yield slides as traders mull over Democrats' midterm victories, oil prices drop

Sherrod Brown wins Ohio despite crypto’s costliest $63 million bet